Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.820
+0.040 (2.25%)
At close: Aug 7, 2026, 4:00 PM EDT
1.839
+0.019 (1.02%)
After-hours: Aug 7, 2026, 4:19 PM EDT

Gain Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7813559533765
Market Cap Growth
34.46%131.16%10.59%42.48%-42.36%-
Enterprise Value
60.48115.3748.8737.2318.3329.25
Last Close Price
1.823.222.163.273.135.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---960.42265.47391.09
PB Ratio
5.407.307.984.211.971.85
P/TBV Ratio
4.755.756.863.441.991.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---674.68130.83177.31

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.050.050.050.04
Net Debt / Equity Ratio
-1.13-1.08-1.33-1.25-1.00-1.01
Net Debt / EBITDA Ratio
0.811.080.480.711.072.55
Net Debt / FCF Ratio
0.821.090.520.841.272.83
Asset Turnover
-000.000.000.01
Quick Ratio
4.266.222.663.394.8814.45
Current Ratio
4.696.632.973.595.1114.78
Return on Equity (ROE)
-130.42%-155.66%-204.95%-141.57%-65.52%-67.73%
Return on Assets (ROA)
-99.19%-111.87%-136.01%-104.58%-56.66%-56.93%
Return on Capital Employed (ROCE)
-114.78%-135.20%-186.09%-132.33%-63.03%-62.96%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-42.24%-44.08%-75.86%-9.49%-16.90%-279.11%
Total Shareholder Return
-42.24%-44.08%-75.86%-9.49%-16.90%-279.11%
SEC Filings: 10-K · 10-Q